UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Annals of oncology, 2014-08, Vol.25 (8), p.1544-1550

2014

Volltextzugriff (PDF)

Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi125-vi132

2013

Volltextzugriff (PDF)

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi106-vi114

2013

Volltextzugriff (PDF)

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v137-v139

2010

Volltextzugriff (PDF)

Prostate cancer: ESMO Consensus Conference Guidelines 2012

Annals of oncology, 2013-05, Vol.24 (5), p.1141-1162

2013

Volltextzugriff (PDF)

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2012-10, Vol.23 Suppl 7, p.vii65-vii71

2012

Volltextzugriff (PDF)

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v129-v133

2010

Volltextzugriff (PDF)

Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv10-iv14

2009

Volltextzugriff (PDF)

Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi115-vi124

2013

Volltextzugriff (PDF)

Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies

BMC medical informatics and decision making, 2021-06, Vol.21 (1), p.205-205, Article 205

2021

Volltextzugriff (PDF)

Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis

Clinical cancer research, 2004-11, Vol.10 (22), p.7621-7628

2004

Volltextzugriff (PDF)

Nationwide survey on patients’ and professionals’ expectations on prognosis of metastatic colorectal cancer (mCRC)

European journal of cancer (1990), 2017-02, Vol.72, p.S50-S50

2017

Volltextzugriff (PDF)

Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2011-09, Vol.22 (suppl_6), p.vi45-vi49

2011

Volltextzugriff (PDF)

Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2008-05, Vol.19 (suppl-2), p.ii11-ii13

2008

Volltextzugriff (PDF)

Predicting Objective Response Rate (ORR) in Immune Checkpoint Inhibitor (ICI) Therapies with Machine Learning (ML) by Combining Clinical and Patient-Reported Data

Applied sciences, 2022-02, Vol.12 (3), p.1563

2022

Volltextzugriff (PDF)

Renal cell carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv81-iv82

2009

Volltextzugriff (PDF)

Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v140-v146

2010

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i34-i36

2005

Volltextzugriff (PDF)

Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v134-v136

2010

Volltextzugriff (PDF)

Burden of Prostate Cancer and Future Need for Health Care Services

Value in health, 2014-11, Vol.17 (7), p.A626-A626

2014

Volltextzugriff (PDF)

Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv76-iv78

2009

Volltextzugriff (PDF)

Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2009-05, Vol.20 (suppl-4), p.iv79-iv80

2009

Volltextzugriff (PDF)

Testicular seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of oncology, 2008-05, Vol.19 (suppl-2), p.ii49-ii51

2008

Volltextzugriff (PDF)

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC)

Annals of oncology, 2005-01, Vol.16 (suppl-1), p.i10-i12

2005

Volltextzugriff (PDF)

Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v147-v154

2010

Volltextzugriff (PDF)

1 – 25 von 263

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(237)
Mit Volltextzugriff
(235)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Prostate cancer: ESMO Consensus Conference Guidelines 2012

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies

Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis

Nationwide survey on patients’ and professionals’ expectations on prognosis of metastatic colorectal cancer (mCRC)

Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Predicting Objective Response Rate (ORR) in Immune Checkpoint Inhibitor (ICI) Therapies with Machine Learning (ML) by Combining Clinical and Patient-Reported Data

Renal cell carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Testicular seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer

Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up

Burden of Prostate Cancer and Future Need for Health Care Services

Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Testicular seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC)

Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Suchergebnisse filtern